The 2nd call results of the NanoBio4Can Project, a research and training fellowship programme for postdoctoral researchers aiming to develop Nano-Biotechnologies for Innovative Therapeutic Approaches in Cancer, have been announced.
The NanoBio4Can Project, under the Scientific Excellence component of the Horizon Europe Programme, which aims to conduct postdoctoral research on drug development, drug delivery and target systems development, testing and validation systems, is an accelerator program specially designed not only for academic studies focused on cancer research but also to develop the entrepreneurial mindset in early-stage researchers.
NanoBio4Can, a joint research and education program that aims to train 24 postdoctoral researchers in the field of “Nanobiotechnology and Cancer,” is being carried out by SUNUM in collaboration with three leading research centers in the life sciences: TÜBİTAK Marmara Research Center (TÜBİTAK-MAM), Koç University Translational Medicine Research Center (KUTTAM), and İzmir Biomedicine and Genome Center (İBG).
Please click to view NanoBio4Can 2nd call results nanobio4can.net
NanoBio4Can Project is funded by the European Union and TÜBİTAK. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or TÜBİTAK. Neither the European Union nor the TÜBİTAK can be held responsible for them.